This study was conducted by Hai Fang and his team from Peking University and published in Human Vaccines & Immunotherapeutics. The study evaluated the cost-effectiveness of using non-immunization program vaccines as an alternative to current vaccination strategies and simulated the economic and health consequences of meningococcal disease using four vaccination strategies based on the 2019 birth cohort. The result showed that using quadrivalent polysaccharide vaccine (MPV-4), bivalent conjugate vaccine (MCV-AC), and quadrivalent conjugate vaccine (MCV-4) could have increased health benefits but at a higher cost. The new strategies would be cost-effective provided lowering vaccine price.
Factors associated with timely vaccination of pertussis-containing vaccines in children born from 2019 to 2023, Shanghai
This study was conducted by Prof Weibing Wang and his team from Fudan University and published in Chinese Journal of Epidemiology. The study analyzed t factors associated with timely vaccination of pertussis-containing vaccines in children born in Shanghai from 2019 to 2023. The results showed that the average vaccination coverage rate was as high as 94.71%-99.53%, but the timely vaccination rate decreased with the increase of doses. The study concludes that pertussis-containing vaccine(DTaP-Hib and DTaP-IPV-Hib)are commonly used and substitute the NIP DTaP vaccine in Shanghai, with high coverage and timely vaccination rates, but some children experience delayed or missed vaccinations, warranting ongoing attention.